June 9 (Reuters) – Privately held Element Biosciences said on Tuesday it had raised funds, including $175 million from longtime investor Samsung Electronics, to expand commercialisation of its genetic
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Maldini resigns from Italy federation after Pirlo coaching plan collapses
VIDEO SHOWS: ARCHIVE OF PAOLO MALDINI, ANDREA PIRLO AND GIOVANNI MALAGO SHOWS: SALERNO, ITALY (ARCHIVE…
FAA PROPOSES RULE REQUIRING AIRLINES TO FIX THE SEATS
FAA PROPOSES RULE REQUIRING AIRLINES TO FIX THE SEATS (The article has been published through…
Way cleared for pop singer D4vd to stand trial on murder, mutilation charges
By Steve Gorman LOS ANGELES, July 27 (Reuters) - Prosecutors have presented sufficient evidence for…
